Boston CE marks Taxus Element
This article was originally published in Clinica
Boston Scientific has CE marked its Taxus Element paclitaxel-eluting stent for sale in Europe. The "third-generation" device is made of a platinum chromium alloy which is stronger and more flexible than older alloys such as cobalt chromium, the company claims. The CE mark also specifically states that the stent can be used in diabetic patients. Boston (Natick, Massachusetts) plans to launch Taxus Element in the EU and other countries that recognise the CE mark next month, and expects US FDA approval to follow in mid-2011. The firm CE marked another stent that uses the same platinum chromium alloy, the everolimus-eluting Promus Element, last November (www.clinica.co.uk, 3 November 2009).